vs
Side-by-side financial comparison of INDEPENDENCE REALTY TRUST, INC. (IRT) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
INDEPENDENCE REALTY TRUST, INC. is the larger business by last-quarter revenue ($165.3M vs $158.6M, roughly 1.0× Stoke Therapeutics, Inc.). On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 2.5%).
Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
IRT vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $165.3M | $158.6M |
| Net Profit | — | $112.9M |
| Gross Margin | — | — |
| Operating Margin | — | 70.2% |
| Net Margin | — | 71.2% |
| Revenue YoY | 2.5% | 3661.1% |
| Net Profit YoY | — | 528.0% |
| EPS (diluted) | $0.00 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $165.3M | — | ||
| Q4 25 | $167.1M | — | ||
| Q3 25 | $167.1M | — | ||
| Q2 25 | $162.2M | — | ||
| Q1 25 | $161.2M | $158.6M | ||
| Q4 24 | $161.0M | $22.6M | ||
| Q3 24 | $160.1M | — | ||
| Q2 24 | $158.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $33.3M | — | ||
| Q3 25 | $6.9M | — | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $8.4M | $112.9M | ||
| Q4 24 | $-1.0M | $-10.5M | ||
| Q3 24 | $12.4M | — | ||
| Q2 24 | $10.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 70.2% | ||
| Q4 24 | — | -60.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 19.9% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 5.0% | — | ||
| Q1 25 | 5.2% | 71.2% | ||
| Q4 24 | -0.6% | -46.4% | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 6.5% | — |
| Q1 26 | $0.00 | — | ||
| Q4 25 | $0.14 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.03 | — | ||
| Q1 25 | $0.04 | $1.90 | ||
| Q4 24 | $-0.01 | $-0.15 | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.3M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.4B | $350.1M |
| Total Assets | $6.1B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $23.3M | — | ||
| Q4 25 | $23.6M | — | ||
| Q3 25 | $23.3M | — | ||
| Q2 25 | $19.5M | — | ||
| Q1 25 | $29.1M | $274.8M | ||
| Q4 24 | $21.2M | $128.0M | ||
| Q3 24 | $17.6M | — | ||
| Q2 24 | $21.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.5B | — | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $3.5B | $350.1M | ||
| Q4 24 | $3.4B | $229.0M | ||
| Q3 24 | $3.4B | — | ||
| Q2 24 | $3.4B | — |
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.0B | — | ||
| Q3 25 | $6.1B | — | ||
| Q2 25 | $6.0B | — | ||
| Q1 25 | $6.0B | $406.9M | ||
| Q4 24 | $6.1B | $271.6M | ||
| Q3 24 | $5.9B | — | ||
| Q2 24 | $5.9B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.65× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.66× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $282.1M | — | ||
| Q3 25 | $79.3M | — | ||
| Q2 25 | $82.2M | — | ||
| Q1 25 | $60.4M | $131.8M | ||
| Q4 24 | $259.8M | $-23.2M | ||
| Q3 24 | $69.2M | — | ||
| Q2 24 | $83.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $131.7M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 83.0% | ||
| Q4 24 | — | -102.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.48× | — | ||
| Q3 25 | 11.51× | — | ||
| Q2 25 | 10.22× | — | ||
| Q1 25 | 7.23× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.60× | — | ||
| Q2 24 | 8.02× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRT
| Rental and other property revenue | $165.2M | 100% |
| Other revenue | $109.0K | 0% |
STOK
Segment breakdown not available.
